|
ZNF197 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.03249631067115E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.16549999651383E-08 |
| Normal-vs-Stage2 |
7.84590000000307E-05 |
| Normal-vs-Stage3 |
9.17177445103334E-12 |
| Normal-vs-Stage4 |
1.45449985389234E-10 |
| Stage1-vs-Stage2 |
7.816200E-01 |
| Stage1-vs-Stage3 |
6.723300E-03 |
| Stage1-vs-Stage4 |
1.464920E-03 |
| Stage2-vs-Stage3 |
2.894300E-02 |
| Stage2-vs-Stage4 |
1.072290E-02 |
| Stage3-vs-Stage4 |
5.735000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.95776769532586E-13 |
| Normal-vs-AfricanAmerican |
4.962300E-03 |
| Normal-vs-Asian |
2.14099999999995E-05 |
| Caucasian-vs-AfricanAmerican |
1.605350E-01 |
| Caucasian-vs-Asian |
3.862300E-02 |
| AfricanAmerican-vs-Asian |
8.858800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.77430000031431E-07 |
| Normal-vs-Female |
4.00346422679831E-12 |
| Male-vs-Female |
1.996410E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.07140000496997E-08 |
| Normal-vs-Age(41-60Yrs) |
1.67930003236449E-10 |
| Normal-vs-Age(61-80Yrs) |
5.81560000156855E-09 |
| Normal-vs-Age(81-100Yrs) |
7.168200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.431600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.930600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.895570E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.381000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.229600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.301200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.31399999999616E-05 |
| Classical-VS-Follicular |
1.178820E-01 |
| Classical-VS-Other |
7.601600E-01 |
| Classical-VS-Normal |
1.33379973732417E-10 |
| Tall-VS-Follicular |
2.05729999999127E-05 |
| Tall-VS-Other |
1.282440E-01 |
| Tall-VS-Normal |
9.74897940153596E-12 |
| Follicular-VS-Other |
4.751400E-01 |
| Follicular-VS-Normal |
1.220280E-04 |
| Other-VS-Normal |
1.547800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.32379995643595E-09 |
| Normal-vs-N1 |
9.12510000894429E-09 |
| N0-vs-N1 |
6.190000E-02 |
|
|
